Biovica International AB (publ) (BIOVIC_B) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biovica International Ab Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.235 and welcome to Bayer-Vika 00:00:03.235 -- 00:00:07.418 Q4 and full year presentation. 00:00:09.043 -- 00:00:14.250 My name is Anders Rulander, and I will be presenting together with the CFO, 00:00:14.250 -- 00:00:20.358 Anders Morén. And here's the agenda for the presentation. 00:00:20.358 -- 00:00:25.164 We'll start with a short introduction to Bayer-Vika, the company and the product. 00:00:25.164 -- 00:00:31.140 We'll go through the Q4 highlights, And then Anders will do the financial 00:00:31.140 -- 00:00:33.582 update. And then we will 00:00:33.582 -- 00:00:38.148 finally do a summary and open up for our Q&A session. 00:00:38.148 -- 00:00:40.610 During the Q&A session, 00:00:40.610 -- 00:00:45.056 we will have Johan and Iris, our analysts from Redeye, to ask questions. 00:00:45.056 -- 00:00:49.841 But you could also, as a participant, submit questions 00:00:49.841 -- 00:00:52.722 using the form 00:00:52.784 -- 00:00:55.605 in the Teams application. 00:00:58.351 -- 00:01:02.778 And if I should move into the 00:01:02.778 -- 00:01:08.024 BioVica introduction, I'll start talking about our product Divitum. 00:01:08.128 -- 00:01:14.118 Divitum is a tool for measuring cell proliferation from a simple blood sample. 00:01:14.118 -- 00:01:20.008 And we do that by measuring an enzyme, which is closely related to the cell proliferation 00:01:20.008 -- 00:01:24.693 cycle. This has proven to have several advantages. 00:01:24.693 -- 00:01:26.355 when 00:01:26.355 -- 00:01:31.443 monitoring treatments for cancer patients, as cancer 00:01:31.443 -- 00:01:36.510 grows through cell proliferation, and it correlates both to before start of treatment, 00:01:36.510 -- 00:01:41.657 how aggressive the disease is, but also it provides quick feedback 00:...